Condition: Mild Cognitive Impairment · Memory Impairment · Sponsor: University of North Texas Health Science Center
This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).
This description comes directly from the study's public registry record.
Xiangrong Shi, PhD · 817-735-2073 · xiangrong.shi@unthsc.edu
Always discuss trial participation with your own doctor first.
| University of North Texas Health Science Center | Fort Worth, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05495087